A trial of two questions

Journal of Clinical Oncology

Volumn 20, Issue 20, 2002, Pages 4135-4138

  Whelan, Tim ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; EDITORIAL; HUMAN; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0037108932     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.20.4135     Document Type: Editorial

References (42)

1. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
2. Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. J Natl Cancer Inst 88:1659-1664, 1996
3. Liljegren G, Holmberg L, Bergh J, et al: 10-year results after sector resection with or without postoperative radiotherapy for stage 1 breast cancer: A randomized trial. J Clin Oncol 17:2326-2333, 1999
4. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001
5. Forrest AP, Stewart HJ, Everington D, et al: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348:708-713, 1996
6. Holli K, Saaristo R, Isola J, et al: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 84:164-169, 2001
7. The Uppsala-Örebro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy for stage 1 breast cancer: A randomized trial. J Natl Cancer Inst 82:277-282, 1990
8. Veronesi U, Luini A, Del Vecchio M, et al: Radiotherapy after breast-conserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591, 1993
9. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002
10. Fisher ER, Anderson S, Tan-Chiu E, et al: Fifteen-year prognostic discriminants for invasive breast carcinoma. Cancer 91:1679-1687, 2001
11. Schnitt SJ, Hayman J, Gelman R, et al: A prospective study of conservative surgery alone in the treatment of selected patients with stage 1 breast cancer. Cancer 77:1094-1100, 1996
12. Goldhirsch A, Wood WC, Senn HJ, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 87:1441-1445, 1995
13. The Steering Committee on Clinical Practice: Guidelines for the care and treatment of breast cancer: Adjuvant systemic therapy for women with node-negative breast cancer. CMAJ 158:S43-S51, 1998
14. Fisher B, Dignam J, Tan-Chiu E, et al: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 93:112-120, 2001
15. Lippman ME, Hayes DF: Adjuvant therapy for all patients with breast cancer? J Natl Cancer Inst 93:80-82, 2001
16. Mirchandani D, Muggia F: Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 93:1420-1421, 2001
17. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467, 1998
18. Loprinzi CL, Ravdin RM, de Laurentiis M, et al: Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 12:1422-1426, 1994
19. O'Connor AM, Llewellyn-Thomas HA, Sawka C, et al: Physicians' opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer. Patient Educ Couns 30:143-153, 1997
20. Siminoff LA, Fetting JH, Abeloff MD: Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192-1200, 1990
21. Ravdin PM, Siminoff IA, Harvey JA: Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16:515-521, 1998
22. Degner LF, Kristjanson L, Bowman D, et al: Information needs and decisional preferences in women with breast cancer. JAMA 277:1485-1492, 1997
23. Levine MN, Gafni A, Markham B, et al: A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117:53-58, 1992
24. Ravdin PM, Siminoff LA, Davis GJ, et al: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19:980-991, 2001
25. Sepucha KR, Belkora JK, Tripathy D, et al: Building bridges between physicians and patients: Results of a pilot study examining new tools for collaborative decision making in breast cancer. J Clin Oncol 18:1230-1238, 2000
26. Molennar S, Sprangers MA, Rutgers EJ, et al: Decision support for patients with early-stage breast cancer: Effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol 19:1676-1687, 2001
27. Whelan TJ, Levine MN, Gafni A, et al: Breast irradiation post-lumpectomy: Development and evaluation of a decision instrument. J Clin Oncol 13:847-853, 1995
28. Whelan T, Sawka C, Levine M, et al: A randomized trial of a decision aid for the use of adjuvant chemotherapy in women with node-negative breast cancer. Proc Am Soc Clin Oncol 20:237a, 2001 (abstr 946)
29. Ravdin PM, Siminoff L, Hewlett J, et al: Evaluation of impact of communication tool generated by the computer program Adjuvant!, on patients with early breast cancer and their doctors. Proc Am Soc Clin Oncol 20:31a 2001 (abstr 119)
30. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with nodenegative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989
31. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90:1371-1388, 1998
32. Dignam JJ, Fisher B: Occurrence of stroke with tamoxifen in NSABP B-24. Lancet 355:848-849, 2000
33. Day R, Ganz PA, Costantino JP, et al: Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Clin Oncol 17:2659-2669, 1999
34. Whelan T, Levine M, Julian J, et al: The effects of radiation therapy on quality of life of women with breast cancer: Results of a randomized trial. Cancer 88:2260-2266, 2000
35. Coates AS, Simes RJ: Patient assessment of adjuvant treatment in operable breast cancer, in Williams CJ (ed): Introducing New Treatments for Cancer: Practical, Ethical, and Legal Problems. New York, NY, John Wiley & Sons, 1992, pp 447-458
36. Lindley C, Vasa S, Sawyer WT, et al: Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:380-387, 1998
37. Gafni A, Birch S: Guidelines for the adoption of new technologies: A prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J 148:913-917, 1993
38. Fyles A, McCready D, Manchul L, et al: Preliminary results of a randomized study of tamoxifen +/- breast radiation in T1/2 NO disease in women over 50 years of age. Proc Am Soc Clin Oncol 20:24a, 2001 (abstr 92)
39. Hughes KS, Schnaper L, Berry D, et al: Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage 1, estrogen receptor positive (ER+) breast carcinoma. Proc Am Soc Clin Oncol 20:24a, 2001 (abstr 93)
40. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89:1673-1682, 1997
41. The ATAC Trialists' Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139, 1002
42. Houghton J, Baum M, Rutqvist LE, et al: The ZIPP trial of adjuvant Zoladex in premenopausal patients with early breast cancer: An update at five years. Proc Am Soc Clin Oncol 19:93a, 2000 (abstr 359)